Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2019

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Presenter: Giuseppe Sangiorgi

September 28, 2019

Presentation TCT 2019

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Presenter: Sreekala Padmanabhan

September 28, 2019

Presentation TCT 2019

Xtreme FIM: Clinical Outcome and Safety in Peripheral Vascular Disease With Sirolimus-Coated Balloon (And Case Report)

Presenter: Sameer Dani

September 28, 2019

Presentation TCT 2019

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

Presenter: Edward Choke

September 28, 2019

Presentation TCT 2019

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Presenter: Aloke Finn

September 28, 2019

Presentation TCT 2019

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

Presenter: George Dangas

September 28, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

Presentation ISET 2019

Systemic Cardiovascular Risks in PAD Patients: The Scope of the Problem

Presenter: John Bartholomew

January 30, 2019

Advertisement

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Xtreme FIM: Clinical Outcome and Safety in Peripheral Vascular Disease With Sirolimus-Coated Balloon (And Case Report)

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Systemic Cardiovascular Risks in PAD Patients: The Scope of the Problem

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content